WESTLAKE CORP — Proxy Solicitation & Information Statement 2016

Jun 10, 2016

DFAN14A 1 d207560ddfan14a.htm DFAN14A DFAN14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ¨ Filed by a party other than the Registrant x

Check the appropriate box:

¨	Preliminary Proxy Statement
¨	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨	Definitive Proxy Statement
x	Definitive Additional Materials
¨	Soliciting Material Under § 240.14a-12

AXIALL CORPORATION

(Name of Registrant as Specified In Its Charter)

WESTLAKE CHEMICAL CORPORATION

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x	No fee required.
¨	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:
¨	Fee paid previously with preliminary materials.
¨	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
	(1)	Amount previously paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing party:
	(4)	Date Filed:

On February 16, 2016, Westlake Chemical Corporation (“Westlake Chemical”) and Westlake NG IV Corporation (“Westlake NG IV” and together with Westlake Chemical, “Westlake”) nominated nine candidates (the “Nomination”) to stand for election to the Board of Directors of Axiall, at Axiall’s upcoming 2016 annual meeting of stockholders (the “Annual Meeting”).

On June 10, 2016, Westlake withdrew the Nomination and agreed that at the Annual Meeting, it will vote all of the shares of Axiall common stock beneficially owned by it in accordance with the recommendation of Axiall’s Board of Directors.